Clinical trials in high-risk medulloblastoma: evolution of the SIOP-Europe HR-MB trial
S Bailey, N André, L Gandola, M Massimino… - Cancers, 2022 - mdpi.com
Simple Summary Patients with medulloblastoma receive treatment according to a risk
stratification, which is a combination of clinical and biological factors. To date there have …
stratification, which is a combination of clinical and biological factors. To date there have …
Medulloblastoma and the DNA damage response
LF McSwain, KK Parwani, SW Shahab… - Frontiers in …, 2022 - frontiersin.org
Medulloblastoma (MB) is the most common malignant brain tumor in children with standard
of care consisting of surgery, radiation, and chemotherapy. Recent molecular profiling led to …
of care consisting of surgery, radiation, and chemotherapy. Recent molecular profiling led to …
Recurrent brain tumors at the largest referral facility in east and central Africa-epidemiology, patterns and outcomes: a descriptive study
JG Kiboi, MA Omar, AW Ngima… - East African Journal of …, 2022 - theeajns.org
Introduction: The prognosis of brain tumors once treated is variable with outcomes ranging
from complete resolution of symptoms to recurrence of the tumor. Different geographical …
from complete resolution of symptoms to recurrence of the tumor. Different geographical …
[HTML][HTML] A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma
With a thorough investigation of the etiology of medulloblastomas, a comprehensive review
was done to categorize available clinical trials in order to discuss the future potential of …
was done to categorize available clinical trials in order to discuss the future potential of …